SBC Medical Group Holdings Incorporated (NASDAQ: SBC) announced the pricing of a secondary public offering of 3.1 million shares of common stock at $3.25 per share. Dr. Yoshiyuki Aikawa is the selling stockholder and will receive all proceeds from the offering.

The company will not sell any shares in the offering. The selling stockholder has granted underwriters a 45-day option to purchase up to an additional 465,000 shares. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions.

Maxim Group LLC is serving as the sole book-running manager and Roth Capital Partners is acting as co-manager for the offering. The offering is being conducted pursuant to the company's effective shelf registration statement on Form S-3 filed with the Securities and Exchange Commission.

SBC Medical operates as a management service organization with franchise businesses across medical fields including aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment, and ophthalmology. The company manages clinic brands and has operations in the United States and Asia.

The company was listed on Nasdaq in September 2024 and was selected for inclusion in the Russell 3000 Index in June 2025, according to the press release.